Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $51.88M.
ENTERPRISE VALUE (EV)
$51.88M
ProQR Therapeutics N.V.
Market Cap
$173.23M
Enterprise Value (EV)
$51.88M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| ProQR Therapeutics N.V. (PRQR) | $173.23M | $51.88M |
| Precision BioSciences, Inc. (DTIL)vs › | $172.81M | $114.83M |
| Cue Biopharma, Inc. (CUE)vs › | $172.53M | $163.94M |
| Compass Therapeutics, Inc. (CMPX)vs › | $175.39M | $149.57M |
| Organogenesis Holdings Inc. (ORGO)vs › | $170.49M | $191.35M |
| Journey Medical Corporation (DERM)vs › | $176.55M | $176.45M |
| MediWound Ltd. (MDWD)vs › | $169.76M | $174.95M |
| Nkarta, Inc. (NKTX)vs › | $169.56M | $218.14M |
| Yarrow Bioscience Inc (YARW)vs › | $176.97M | $154.04M |
| OptimizeRx Corp. (OPRX)vs › | $166.07M | $161.45M |
Market Cap
$173.23M
Total Debt
$6.13M
Cash
$127.48M
Enterprise Value
$51.88M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
